Abstract
The pathogenesis of atherosclerosis involves the interplay of inflammation, altered cellular activity, angiogenesis, and neointima formation. The main cellular participants in atherosclerosis include vascular endothelial cells, smooth muscle cells, and monocytes. The recent discovery of small, non-coding RNAs, microRNAs (miRNAs), and their influence on these processes has provided a greater molecular insight into atherosclerosis. This in turn has led to increase focus on the potential utility of miRNA subtypes as biomarkers for coronary artery disease. Furthermore miRNAs could potentially provide therapeutic targets for the treatment of atherosclerosis and its complications. In this review, we discuss the experimental and clinical evidence for the role of miRNAs in the pathogenesis of coronary artery disease, the limitations of the data and challenges facing the field.
Keywords: Atherosclerosis, coronary artery disease, microRNA, myocardial Infarction, novel risk factors, plaque rupture.
MicroRNA
Title:MicroRNA Expression in Coronary Artery Disease
Volume: 2 Issue: 3
Author(s): John F. O`Sullivan, Antoinette Neylon, Catherine McGorrian and Gavin J. Blake
Affiliation:
Keywords: Atherosclerosis, coronary artery disease, microRNA, myocardial Infarction, novel risk factors, plaque rupture.
Abstract: The pathogenesis of atherosclerosis involves the interplay of inflammation, altered cellular activity, angiogenesis, and neointima formation. The main cellular participants in atherosclerosis include vascular endothelial cells, smooth muscle cells, and monocytes. The recent discovery of small, non-coding RNAs, microRNAs (miRNAs), and their influence on these processes has provided a greater molecular insight into atherosclerosis. This in turn has led to increase focus on the potential utility of miRNA subtypes as biomarkers for coronary artery disease. Furthermore miRNAs could potentially provide therapeutic targets for the treatment of atherosclerosis and its complications. In this review, we discuss the experimental and clinical evidence for the role of miRNAs in the pathogenesis of coronary artery disease, the limitations of the data and challenges facing the field.
Export Options
About this article
Cite this article as:
F. O`Sullivan John, Neylon Antoinette, McGorrian Catherine and J. Blake Gavin, MicroRNA Expression in Coronary Artery Disease, MicroRNA 2013; 2 (3) . https://dx.doi.org/10.2174/22115366113026660018
DOI https://dx.doi.org/10.2174/22115366113026660018 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
Call for Papers in Thematic Issues
Modulatory Roles of Non-coding RNAs in cancer therapy
This thematic issue aims to elucidate the most recent research on ncRNAs in CRCs and discuss the importance and difficulties that may arise in applying this tool on a regular clinical basis.read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Medical Treatment of Uterine Arteriovenous Malformations: A Case Report
Current Women`s Health Reviews Meet Our Editor:
Current Cardiology Reviews Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Current Pharmaceutical Design Infection-Associated Biomarkers of Inflammation in Atherosclerosis
Current Pharmaceutical Design Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews Association of Large Vessel Aneurysm/Pseudo-Aneurysm/Aortitis and Deep Vein Thrombosis in Patients with Behçet’s Disease: A Case Report
Current Rheumatology Reviews Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Current Cancer Drug Targets Imaging of Abdominal Aortic Aneurysm: The Present and the Future
Current Vascular Pharmacology Peripheral Vascular Disease: The Role of MR- Angiography
Current Medical Imaging MMP-2 Selectivity in Hydroxamate-Type Inhibitors
Current Medicinal Chemistry Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
Current Pharmaceutical Design The Obesity-associated Risk in Open and Endovascular Repair of Abdominal Aortic Aneurysm
Current Pharmaceutical Design Pulmonary Complications After Congenital Heart Surgery
Current Respiratory Medicine Reviews Vascular Endothelial Primary Cilia: Mechanosensation and Hypertension
Current Hypertension Reviews The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury
Current Pharmaceutical Design Editorial (Thematic Issue: Novel Insights on Aortic Aneurysm)
Current Pharmaceutical Design High-pitch Dual-source CT Angiography before TAVI - the Value of ECG Gating
Current Medical Imaging Usefulness of Magnetic Resonance Imaging in Cardiac and Enovascular Intervention
Current Medical Imaging Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
Current Drug Targets